About Us
Bringing innovative and advanced technologies to patients with severe medical conditions
WHO WE ARE
KELI Therapeutics is a regenerative medicine company focused on solving serious medical conditions through advanced biologics.
We specialize in cell and gene-based therapies, tissue-derived products, and exosome technologies that target inflammation, tissue damage, and immune dysfunction. Our work spans non-clinical and clinical development, GMP manufacturing, and global commercialization.
KELI operates as a licensed tissue establishment and is preparing multiple product launches across inflammatory conditions, orthopedics, nephrology, dermatology, and the wellness sectors.
We are headquartered in Europe and operate with a global mindset—working with partners, clinics, and distributors across key markets.
BRINGING TOMORROW'S SOLUTIONS TO TODAY'S CHALLENGES
MEET THE LEADERS GUIDING KELI THERAPEUTICS
KELI Therapeutics' leadership is comprised of industry veterans and passionate experts committed to transforming lives affected by unmet medical needs. Our executive team and board of directors are driven by a genuine love for their work and the profound impact it can have on patients, families, and communities worldwide. Complementing this expertise, advisory board, with decades of experience in clinical practice, biotechnology, immunology, and regulation, provides invaluable insights into the latest scientific discoveries, emerging trends, and industry best practices.